Safety and Efficacy of DIT309 in Advanced Bone and Soft Tissue Sarcomas

NCT07052383 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteosarcoma
Soft Tissue Sarcoma

Interventions

BIOLOGICAL: DIT309 cell injection

Sponsor

Tcelltech Inc.

Collaborators

[object Object]